PMV PHARMACEUTICALS, - REZATAPOPT SHOWS FAVORABLE SAFETY PROFILE WITH 5% DISCONTINUATION RATE DUE TO ADVERSE EVENTS

Reuters · 3d ago

Please log in to view news